Importance of resection margin after resection of colorectal liver metastases in the era of modern chemotherapy: population-based cohort study

被引:1
|
作者
Ostrand, Emil [1 ,2 ]
Rystedt, Jenny [1 ,2 ]
Engstrand, Jennie [3 ,4 ]
Fruhling, Petter [5 ,6 ]
Hemmingsson, Oskar [7 ]
Sandstrom, Per [8 ,9 ]
Eilard, Malin Sternby [10 ,11 ]
Tingstedt, Bobby [1 ,2 ]
Buchwald, Pamela [12 ,13 ]
机构
[1] Skane Univ Hosp, Dept Surg, SE-22185 Lund, Sweden
[2] Lund Univ, Dept Clin Sci Lund, Lund, Sweden
[3] Karolinska Univ Hosp, Div Surg, Stockholm, Sweden
[4] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden
[5] Akad Univ Hosp, Dept Surg, Uppsala, Sweden
[6] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[7] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden
[8] Linkoping Univ Hosp, Dept Surg, Linkoping, Sweden
[9] Linkoping Univ, Dept Clin & Expt Med Sci, Linkoping, Sweden
[10] Sahlgrens Univ Hosp, Dept Transplantat & Liver Surg, Gothenburg, Sweden
[11] Univ Gothenburg, Sahlgrenska Acad, Dept Clin Sci, Gothenburg, Sweden
[12] Skane Univ Hosp, Dept Surg, Malmo, Sweden
[13] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden
来源
BJS OPEN | 2024年 / 8卷 / 03期
关键词
HEPATIC RESECTION; SURGICAL RESECTION; PRIMARY TUMOR; R1; RESECTION; SURVIVAL; CANCER; SCORE; HEPATECTOMY; RECURRENCE; IMPACT;
D O I
10.1093/bjsopen/zrae035
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Resection margin has been associated with overall survival following liver resection for colorectal liver metastasis. The aim of this study was to examine how resection margins of 0.0 mm, 0.1-0.9 mm and >= 1 mm influence overall survival in patients resected for colorectal liver metastasis in a time of modern perioperative chemotherapy and surgery. Methods Using data from the national registries Swedish Colorectal Cancer Registry and Swedish National Quality Registry for Liver, Bile Duct and Gallbladder Cancer, patients that had liver resections for colorectal liver metastasis between 2009 and 2013 were included. In patients with a narrow or unknown surgical margin the original pathological reports were re-reviewed. Factors influencing overall survival were analysed using a Cox proportional hazard model. Results A total of 754 patients had a known margin status, of which 133 (17.6%) patients had a resection margin <1 mm. The overall survival in patients with a margin of 0 mm or 0.1-0.9 mm was 42 (95% c.i. 31 to 53) and 48 (95% c.i. 35 to 62) months respectively, compared with 75 (95% c.i. 65 to 85) for patients with >= 1 mm margin, P < 0.001. Margins of 0 mm or 0.1-0.9 mm were associated with poor overall survival in the multivariable analysis, HR 1.413 (95% c.i. 1.030 to 1.939), P = 0.032, and 1.399 (95% c.i. 1.025 to 1.910), P = 0.034, respectively. Conclusions Despite modern chemotherapy the resection margin is still an important factor for the survival of patients resected for colorectal liver metastasis, and a margin of >= 1 mm is needed to achieve the best possible outcome.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
    Andreou, Andreas
    Aloia, Thomas A.
    Brouquet, Antoine
    Dickson, Paxton V.
    Zimmitti, Giuseppe
    Maru, Dipen M.
    Kopetz, Scott
    Loyer, Evelyne M.
    Curley, Steven A.
    Abdalla, Eddie K.
    Vauthey, Jean-Nicolas
    [J]. ANNALS OF SURGERY, 2013, 257 (06) : 1079 - 1088
  • [2] IMPORTANCE OF SURGICAL RESECTION MARGIN IN COLORECTAL LIVER METASTASES
    She, Wong-Hoi
    Ng, Kelvin K.
    Ma, Ka Wing
    Dai, Wing Chiu
    Chan, Albert
    Chok, Kenneth S.
    Cheung, Tan To
    Lo, Chung Mau
    Law, Wai Lun
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S1297 - S1297
  • [3] A commentary on"Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study" synchronous colorectal liver metastases: simultaneous or staged resection?
    Balci, Deniz
    Ekser, Burcin
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2020, 74 : 118 - 119
  • [4] Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study
    Bogach, Jessica
    Wang, Julian
    Griffiths, Christopher
    Parpia, Sameer
    Saskin, Refik
    Hallet, Julie
    Ruo, Leyo
    Simunovic, Marko
    Serrano, Pablo E.
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2020, 74 : 68 - 75
  • [5] Extending the Limits of Resection for Colorectal Liver Metastases: Positive Resection Margin and Outcome After Resection of Colorectal Cancer Liver Metastases
    Qadan, Motaz
    D'Angelica, Michael I.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (01) : 196 - 198
  • [6] Extending the Limits of Resection for Colorectal Liver Metastases: Positive Resection Margin and Outcome After Resection of Colorectal Cancer Liver Metastases
    Motaz Qadan
    Michael I. D’Angelica
    [J]. Journal of Gastrointestinal Surgery, 2017, 21 : 196 - 198
  • [7] Surgical resection and pen-operative chemotherapy for colorectal cancer liver metastases: A population-based study
    Booth, C. M.
    Nanji, S.
    Wei, X.
    Biagi, J. J.
    Krzyzanowska, M. K.
    Mackillop, W. J.
    [J]. EJSO, 2016, 42 (02): : 281 - 287
  • [8] Simultaneous Versus Staged Resection for Synchronous Colorectal Cancer Liver Metastases: A Population-based Cohort Study
    Bogach, J.
    Wang, J.
    Parpia, S.
    Simunovic, M.
    Hallet, J.
    Aybar, P. Serrano
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S140 - S140
  • [9] Simultaneous versus staged resection for synchronous colorectal cancer liver metastases: A population-based cohort study.
    Aybar, Pablo Emilio Serrano
    Bogach, Jessica
    Wang, Julian
    Parpia, Sameer
    Hallet, Julie
    Simunovic, Marko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Simultaneous versus staged resection for synchronous colorectal cancer liver metastases: A population-based cohort study.
    Bogach, Jessica
    Wang, Julian
    Parpia, Sameer
    Simunovic, Marko
    Hallet, Julie I.
    Aybar, Pablo Emilio Serrano
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)